New points-to-consider in the diagnosis, treatment of systemic hyperinflammatory syndromes
Hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) are life-threatening systemic hyperinflammatory syndromes.
Hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) are life-threatening systemic hyperinflammatory syndromes.
A fundraising ad for U.S. Rep. Matt Rosendale (R-Mont.) shows a photo of Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases, behind bars, swarmed by…
Wildfire smoke. Drought. Brutal heat. Floods. As Californians increasingly feel the health effects of climate change, state leaders are adopting sweeping policies they hope will fend off the worst impacts…
The safety, clinical implications, and challenges of obesity pharmacotherapies based on entero-pancreatic hormone- treatments.
The effectiveness of Cefoxitin in the treatment of Endometritis and Intraamniotic Infections (IAI).
Today, peer-reviewed results from a Phase 3 efficacy trial of the R21/Matrix-M™ malaria vaccine were published in The Lancet. The study was conducted across multiple sites in four African countries with 4,800…
University of Virginia scientists have developed a new approach to machine learning – a form of artificial intelligence – to identify drugs that help minimize harmful scarring after a heart…
The Medicines and Healthcare products Regulatory Agency (MHRA) has designated two new UK Approved Bodies, delivering increased capacity for the certification of the performance and safety of medical devices, for…
Almirall S.A., a global pharmaceutical company focused on medical dermatology, announced today a strategic partnership with Microsoft to drive innovation and digital transformation, advance the research of medical solutions for dermatological…
Where you live must not determine how long you live. Regular testing is needed to end the postcode health lottery, says a leading expert.